❌

Normal view

OpenAI Expands in Malaysia: New AI Data Centers to Deploy Nvidia Vera Rubin

8 September 2026 at 17:00
OpenAI is expanding its AI infrastructure footprint in Malaysia through a Firmus deal for two data centers deploying Nvidia Vera Rubin systems.

South Australia Launches AI Royal Commission: What Businesses Should Expect

10 August 2026 at 17:00
South Australia is launching an AI royal commission to examine how the technology is reshaping work, public services, and the economy. Businesses should expect greater scrutiny of AI governance, privacy, workforce use, and accountability as separate federal standards and privacy rules move forward.

Australia, Singapore Deepen AI and Cybersecurity Cooperation

10 August 2026 at 17:00
Australia and Singapore are expanding cooperation on AI safety, cybersecurity, digital infrastructure, and subsea-cable resilience through their first Cyber and Digital Senior Officials Dialogue.

Microsoft Opens Largest India Data Center as AI Competition Intensifies

7 August 2026 at 19:53
Microsoft has opened its largest India cloud region in Hyderabad as it expands AI infrastructure and competes with Google and Amazon for enterprise demand.

Chinese AI Models Capture 60% of U.S. Business Token Usage on OpenRouter

24 July 2026 at 13:44
Chinese AI models now lead U.S. business usage on OpenRouter, creating cost advantages for companies and a difficult policy challenge for Washington.

Why More Businesses Are Choosing Cheaper Chinese AI Models

17 July 2026 at 22:03
Chinese AI models are gaining business interest as companies weigh lower costs, open-weight flexibility, performance trade-offs, and enterprise risks.

Nvidia Taps Japan’s Robot Giants to Build Smarter Factories

16 July 2026 at 18:47
Nvidia is partnering with Japan’s robotics leaders to develop smarter factories using physical AI, new models, and domestic computing infrastructure.

FDA advisors unanimously vote to approve Moderna's mRNA after agency drama

18 June 2026 at 23:08

Independent advisors for the Food and Drug Administration on Friday voted 9–0 in support of approving Moderna's seasonal mRNA flu vaccine, which a Trump appointee at the agency initially tried to block from even being reviewed.

In an all-day meeting, members of the FDA's advisory committeeβ€”known as VRBPAC for Vaccines and Related Biological Products Advisory Committeeβ€”pored over data and presentations on the vaccine, which is dubbed mRNA-1010 and branded as mFlusiva. The presentations included a review from FDA scientists, which was supportive of the vaccine.

Data from a Phase 3 trial including over 40,000 adults age 50 and older found the mRNA vaccine was around 27 percent more effective against seasonal flu than a standard flu shot. A smaller Phase 3 trial, involving data from nearly 3,000 people age 65 years and older, showed the shot produces stronger immune responses than a high-dose flu vaccine, which is recommended for this age group. The safety profile of the vaccine was also generally good.

Read full article

Comments

Β© DeFodi Images

❌